vancomycin hydrochloride for injection (0.5g)-凯发官网首页

indications

this product is suitable for the treatment of methicillin-resistant staphylococcus aureus cause serious or fatal infections. patients allergic to penicillin and other antibiotics cannot be used include penicillin, cephalosporins, or ineffective treatment of patients infected with staphylococci and enterococci, and vancomycin-sensitive infections caused by bacteria, the product is applicable. when the suspected infection is methicillin-resistant staphylococcus aureus having a resistance caused by vancomycin as initial treatment, but susceptibility testing with the results, treatment should make the appropriate adjustments.

it caused the fda to treat staphylococcal endocarditis good effect. other infections due to staphylococci, including septicemia, bone infections, lower respiratory tract infections, skin and skin structure infections are also effective. when local purulent staphylococcus infection, when antibiotics should be drainage of pus.

the fda alone or with aminoglycoside therapy endocarditis caused by streptococcus viridans, effects is good.

there are reports that there enterococcus (e.g. streptococcus faecalis) endocarditis caused the fda and the need to aminoglycoside side curative.

diphtheroids endocarditis caused by vancomycin therapy.

vancomycin and rifampin, aminoglycosides , or both together and with the initial phases of implantation of prosthetic valve endocarditis class or staphylococcus epidermidis diphtheria caused by the good results.

required for bacterial culture to isolate and identify pathogens and measure the sensitivity of this product.

the american heart association recommends that medical and dental suffering from congenital heart disease, rheumatic fever or acquired valvular heart disease, and in patients with penicillin allergy, respiratory tract during surgery or dental procedures on using this proposal to prevent bacterial endocarditis. however, there are no controlled studies of the clinical efficacy.